Related Experiment Video
Updated: May 23, 2026
Application of a New Mesh Fixation Method in Laparoscopic Incisional Hernia Repair
Published on: December 23, 2022
Minimally invasive component separation results in fewer wound-healing complications than open component separation
Shadi Ghali1, Kristin C Turza, Donald P Baumann
1Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Background:
Minimally invasive component separation (CS) with inlay bioprosthetic mesh (MICSIB) is a recently developed technique for abdominal wall reconstruction that preserves the rectus abdominis perforators and minimizes subcutaneous dead space using limited-access tunneled incisions. We hypothesized that MICSIB would result in better surgical outcomes than conventional open CS.
Study Design:
All consecutive patients who underwent CS (open or minimally invasive) with inlay bioprosthetic mesh for ventral hernia repair from 2005 to 2010 were included in a retrospective analysis of prospectively collected data. Surgical outcomes, including wound-healing complications, hernia recurrences, and abdominal bulge/laxity rates, were compared between patient groups based on the type of CS repair, either MICSIB or open.
Results:
Fifty-seven patients who underwent MICSIB and 50 who underwent open CS were included. Mean follow-ups were 15.2 ± 7.7 months and 20.7 ± 14.3 months, respectively. Mean fascial defect size was significantly larger in the MICSIB group (405.4 ± 193.6 cm(2) vs 273.8 ± 186.8 cm(2); p = 0.002). The incidences of skin dehiscence (11% vs 28%; p = 0.011), all wound-healing complications (14% vs 32%; p = 0.026), abdominal wall laxity/bulge (4% vs 14%; p = 0.056), and hernia recurrence (4% vs 8%; p = 0.3) were lower in the MICSIB group than in the open CS group.
Conclusions:
MICSIB resulted in fewer wound-healing complications than did open CS used for complex abdominal wall reconstructions. These findings are likely attributable to the preservation of paramedian skin vascularity and reduction in subcutaneous dead space with MICSIB. MICSIB should be considered for complex abdominal wall reconstructions, particularly in patients at increased risk of wound-healing complications.
Insights
Minimally invasive component separation (MICSIB) shows fewer wound complications than open surgery for abdominal wall reconstruction. This technique preserves perforators and reduces dead space, improving patient outcomes.
Area of Science:
- Abdominal wall reconstruction
- Surgical innovation
- Hernia repair
Background:
- Minimally invasive component separation (MICSIB) with inlay bioprosthetic mesh is a novel technique for abdominal wall reconstruction.
- It preserves rectus abdominis perforators and minimizes dead space via limited-access incisions.
- This study hypothesized better surgical outcomes with MICSIB compared to conventional open component separation (CS).
Purpose of the Study:
- To compare surgical outcomes between MICSIB and open CS for ventral hernia repair.
- To evaluate wound-healing complications, hernia recurrence, and abdominal wall laxity/bulge rates.
- To determine the efficacy of MICSIB in complex abdominal wall reconstructions.
Main Methods:
- Retrospective analysis of prospectively collected data from 2005-2010.
- Inclusion of consecutive patients undergoing CS (open or minimally invasive) with inlay bioprosthetic mesh.
- Comparison of outcomes between MICSIB (n=57) and open CS (n=50) groups.
Main Results:
- MICSIB group had a larger mean fascial defect size (405.4 cm² vs 273.8 cm²).
- Incidences of skin dehiscence (11% vs 28%), wound complications (14% vs 32%), and abdominal wall laxity/bulge (4% vs 14%) were lower in the MICSIB group.
- Hernia recurrence rates were similar (4% vs 8%).
Conclusions:
- MICSIB demonstrated fewer wound-healing complications compared to open CS for complex abdominal wall reconstructions.
- Preservation of skin vascularity and reduced dead space likely contribute to MICSIB's benefits.
- MICSIB is a recommended option for complex reconstructions, especially in high-risk patients.
